Race Oncology Limited (ASX:RAC)
Australia
· Delayed Price · Currency is AUD 2.870
+0.020 (0.70%)
At close: Dec 5, 2025
Race Oncology Revenue
In the fiscal year ending June 30, 2025, Race Oncology had annual revenue of 6.04M AUD with 24.96% growth. Race Oncology had revenue of 788.42K in the half year ending June 30, 2025, a decrease of -56.50%.
Revenue
6.04M
Revenue Growth
+24.96%
P/S Ratio
84.26
Revenue / Employee
n/a
Employees
n/a
Market Cap
509.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 6.04M | 1.21M | 24.96% |
| Jun 30, 2024 | 4.84M | 1.70M | 54.29% |
| Jun 30, 2023 | 3.13M | 2.43M | 342.83% |
| Jun 30, 2022 | 707.81K | 320.42K | 82.71% |
| Jun 30, 2021 | 387.39K | 228.01K | 143.07% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Pro Medicus | 212.98M |
| Cochlear | 2.34B |
| Sonic Healthcare | 9.65B |
| Ramsay Health Care | 17.79B |
| Ansell | 3.06B |
| Telix Pharmaceuticals | 1.01B |
| Mesoblast | 26.23M |